Practice Areas
Where We
Create Value.
Eight focused practice areas — each designed to address the specific commercial challenges that diagnostics and precision medicine companies face at critical inflection points.
Life Science Dx supports diagnostics, precision medicine, life science tools, and healthcare technology companies across the strategic and operational decisions required to move from scientific promise to market adoption.
How We Work
From Commercial Problem to Executable Program.
Life Science Dx works with leadership, commercial, product marketing, market access, business development, and investor-facing teams to clarify the commercial problem, pressure-test assumptions, and translate strategy into executable programs.
Diagnose the Commercial Problem
Clarify the market, customer, evidence, reimbursement, workflow, adoption, and execution questions that must be answered.
01
Go-to-Market Strategy
From vision to market — with precision.
Life Science Dx helps diagnostics and precision medicine companies build the commercial foundation required to succeed at launch and beyond — defining the right go-to-market model, identifying the highest-value customer segments, and aligning commercial infrastructure to the realities of the diagnostics market.
Best For
Pre-commercial and early-commercial diagnostics companies preparing for launch or pivoting their commercial approach.
Key Deliverables
- Go-to-market strategy and launch roadmap
- Commercial model design (direct, distribution, hybrid)
- Customer segmentation and targeting framework
- Revenue model and pricing architecture
- Sales force sizing and structure
02
Market Assessment & Opportunity Evaluation
Rigorous intelligence for high-stakes decisions.
Sound commercial decisions require a clear-eyed view of market size, customer need, competitive dynamics, adoption barriers, and timing. Life Science Dx helps companies frame the right market questions, structure primary research when needed, leverage trusted research resources, and translate findings into clear commercial decisions.
Best For
Companies evaluating new markets, indications, or geographies — and investors conducting commercial diligence.
Key Deliverables
- Total addressable market sizing and segmentation
- Competitive landscape and positioning analysis
- Customer discovery framework and research-question design
- Market entry feasibility and timing analysis
- Indication prioritization framework
03
Reimbursement & Market Access
Coverage, coding, and access aligned to market reality.
Reimbursement can be one of the most consequential commercial variables for a diagnostic. Life Science Dx helps companies evaluate coding and coverage strategy, define the right reimbursement questions, align evidence planning with payer expectations, and engage specialized reimbursement resources when formal assessment is required.
Best For
Molecular diagnostics, genomics, specialty IVD, and precision medicine companies navigating U.S. coding, coverage, and payment requirements.
Key Deliverables
- Reimbursement pathway review and strategic implications
- Coding strategy guidance, including CPT, PLA, and proprietary-code considerations
- Coverage pathway and payer evidence guidance
- Evidence-generation priorities aligned to access requirements
- Market access launch sequencing
04
Product-Market Fit & Clinical Utility
Validate before you scale.
Many diagnostics companies invest heavily in commercial infrastructure before confirming that their product solves a problem the market will pay to solve. Life Science Dx helps companies test product-market fit by clarifying the customer problem, structuring discovery, assessing clinical utility, and translating feedback into a stronger value proposition.
Best For
Early-stage companies with a product in development or early commercialization seeking to validate and refine their commercial thesis.
Key Deliverables
- Customer discovery framework and interview guide
- Clinical utility and workflow integration assessment
- Value proposition development and testing
- Willingness-to-pay and adoption barrier analysis
- Product positioning and messaging framework
05
Commercial Execution & Sales Optimization
Strategy only creates value when it executes.
Commercial success in diagnostics requires more than a strong strategy — it demands disciplined execution. Life Science Dx helps companies build and optimize the operational infrastructure that drives consistent revenue performance: sales force design, CRM discipline, forecasting rigor, pipeline management, and the commercial processes that turn strategy into results.
Best For
Commercial-stage companies seeking to improve sales productivity, execution consistency, and revenue predictability.
Key Deliverables
- Sales force structure, territory design, and deployment
- Sales messaging and call-point optimization
- CRM implementation guidance and pipeline discipline
- Forecasting methodology and commercial KPI framework
- Sales cadence, coaching infrastructure, and performance management
06
Companion Diagnostics Strategy
Navigating the CDx opportunity with clarity.
Companion diagnostics require alignment across therapeutic strategy, diagnostic evidence, regulatory expectations, laboratory adoption, market access, and commercial execution. Life Science Dx helps diagnostics companies and pharma partners evaluate CDx opportunities, structure the commercial logic for partnerships, and anticipate the practical implications of co-development.
Best For
IVD companies exploring CDx partnerships and pharma companies evaluating diagnostic co-development opportunities.
Key Deliverables
- CDx opportunity assessment and indication prioritization
- Pharma partnership strategy and partner identification
- Co-development strategy and commercial deal-logic support
- Regulatory-commercial pathway considerations
- Commercial launch planning for CDx products
07
Partnership, BD & Investor Support
Partnerships and narratives built on commercial logic.
The right partnerships accelerate commercialization, expand market access, and create strategic optionality. Life Science Dx helps companies define the commercial logic for partnerships, identify and prioritize potential partners, shape the narrative, and build investor-ready commercial stories that hold up under diligence and board-level scrutiny.
Best For
Companies seeking distribution partnerships, co-development agreements, licensing arrangements, strategic alliances, or preparing for fundraising and investor diligence.
Key Deliverables
- Partnership strategy and opportunity mapping
- Target identification and prioritization
- Strategic narrative, partner outreach materials, and pitch development
- Commercial deal-logic and term-sheet input
- Investor presentation development, market sizing review, and diligence preparation
08
Fractional Commercial Leadership
Senior leadership. Right-sized for your stage.
Not every company is ready for a full-time Chief Commercial Officer — but every company benefits from senior commercial judgment. Life Science Dx provides fractional commercial leadership for companies that need executive-level guidance, operating cadence, team mentorship, and board-ready commercial perspective before committing to a full-time hire.
Best For
Interim or part-time senior commercial leadership for companies building, launching, scaling, optimizing, or repositioning.
Key Deliverables
- Ongoing commercial leadership and execution support
- Commercial team hiring, onboarding, and mentorship
- Board and investor commercial reporting
- Cross-functional commercial alignment (R&D, regulatory, finance)
- Commercial infrastructure build-out
Representative Engagement Snapshots
Where Life Science Dx Has Created Value.
Commercialization Readiness
Supported an emerging CLIA-Lab based diagnostic testing company in assessing clinical utility, reimbursement readiness, physician workflow fit, customer segmentation, and launch sequencing before broader market expansion.
Market Access and Coding Strategy
Worked with a diagnostic test company to evaluate coding, coverage, payer evidence needs, payment pathway options, and reimbursement sequencing for a novel cell-free DNA liquid biopsy test.
U.S. Market Entry
Advised EU based companies on U.S. commercialization requirements, market positioning, customer segmentation, partnership options, and launch-readiness priorities.
Investor and Strategic Partner Readiness
Supported leadership teams in translating progress of scientific and clinical value into commercially credible narratives for investors, strategic partners, and internal decision-makers.
Commercial Execution and Scale
Worked with commercial teams (AI Interpretative Digital Pathology, Transplant Medicine, Oncology Prognostic and Diagnostic Testing) to assess sales model design, customer targeting, adoption barriers, workflow integration, and execution priorities required for growth.
Get Started
Not Sure Which Practice Areas Fit Your Situation?
Most engagements begin with a brief conversation. Tell us where you are and where you need to go — Life Science Dx will recommend the right scope.